in an attempt to convert the bone-marrow population from philadelphia-chromosome ( ph-1 ) positivt to partially or wholly ph-1 negative , thioguanine was used as primary therapy in seven patients with chronic granulocytic leukaemia ( c.g.l . ) .
C0039902
thioguanine
C0023473
chronic granulocytic leukaemia